1. Home
  2. TWN vs BNTC Comparison

TWN vs BNTC Comparison

Compare TWN & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TWN

Taiwan Fund Inc. (The)

HOLD

Current Price

$62.50

Market Cap

375.5M

Sector

Finance

ML Signal

HOLD

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$10.73

Market Cap

411.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWN
BNTC
Founded
N/A
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
375.5M
411.4M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
TWN
BNTC
Price
$62.50
$10.73
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$27.67
AVG Volume (30 Days)
23.3K
141.5K
Earning Date
01-01-0001
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.94
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.45
$9.85
52 Week High
$67.83
$17.15

Technical Indicators

Market Signals
Indicator
TWN
BNTC
Relative Strength Index (RSI) 51.80 46.05
Support Level $52.46 $9.89
Resistance Level $64.25 $13.27
Average True Range (ATR) 2.20 0.58
MACD -0.09 -0.05
Stochastic Oscillator 40.00 37.23

Price Performance

Historical Comparison
TWN
BNTC

About TWN Taiwan Fund Inc. (The)

Taiwan Fund Inc is a diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment predominantly in equity securities listed in Taiwan stock exchange and the Republic of China. In selecting the companies for investments fund's portfolio managers will consider overall growth prospects, competitive position in the respective industry technology, research, and development, productivity, profit margins, return on investment, capital resources, government regulation, management and other factors.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Share on Social Networks: